Contraceptive safety among women with cystic fibrosis: a systematic review

Whiteman, Maura K.; Oduyebo, Titilope; Zapata, Lauren B.; Walker, Seth; Curtis, Kathryn M.

doi:10.1016/j.contraception.2016.05.016

Cited by 22 publications

(9 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The CDC lists no contraception contraindications for cystic fibrosis. Some clinicians prefer the transdermal patch, vaginal ring, implant, and IUD to avoid the theoretical concerns of impaired gut absorption and risk of firstpass effect (Roe et al, 2016;Whiteman et al, 2016).…”

Section: Cystic Fibrosismentioning

confidence: 98%

See 1 more Smart Citation

Practice Guideline: Contraception for Adolescents with Chronic Illness

Hall¹,

Rende²

2017

Journal of Pediatric Health Care

View full text Add to dashboard Cite

Section: Cystic Fibrosismentioning

confidence: 98%

“…Unintended pregnancies in patients with cystic fibrosis can be complicated and should involve extensive genetic counseling and disease management (Roe, Traxler, & Schreiber, 2016;Whiteman et al, 2016). The CDC lists no contraception contraindications for cystic fibrosis.…”

Section: Cystic Fibrosismentioning

confidence: 99%

Practice Guideline: Contraception for Adolescents with Chronic Illness

Hall¹,

Rende²

2017

Journal of Pediatric Health Care

View full text Add to dashboard Cite

“…Evidence: Limited evidence suggests that use of COCs or oral contraceptives (type not specified) among women with cystic fibrosis is not associated with worsening of disease severity. Very limited evidence suggests that cystic fibrosis does not impair the effectiveness of hormonal contraception (267).…”

Section: Respiratory Conditionsmentioning

confidence: 99%

CE: An Evidence-Based Update on Contraception

Britton

Alspaugh

Greene

et al. 2020

AJN, American Journal of Nursing

View full text Add to dashboard Cite

Recommendations and Reports Disclosure of Relationship CDC, our planners, and our content experts wish to disclose they have no financial interest or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias. This document will not include any discussion of the unlabeled use of a product or a product under investigational use, with the exception that some of the recommendations in this document might be inconsistent with package labeling.

show abstract

“…Research on contraceptive safety specific to women with CF has been systematically reviewed but remains limited [49]. Most progestin-only methods, such as the progestin IUD, progestin subdermal implant, and progestin-only OCs, as well as non-hormonal methods, such as the copper IUD and barrier methods, carry no theoretical risks in the setting of CF.…”

Section: Contraceptive Safetymentioning

confidence: 99%

Female reproductive health in cystic fibrosis

Hughan

Daley

Rayas³

et al. 2019

Journal of Cystic Fibrosis

View full text Add to dashboard Cite

Women with cystic fibrosis (CF) are living longer and healthier lives, and opportunities for childbearing are increasingly promising. However, this population can also face sexual and reproductive health concerns, including menstrual irregularities, unplanned pregnancies, infertility and pregnancy complications. Additionally, more women are entering menopause and are at risk for the consequences of estrogen deficiency. The exact mechanisms involved in female reproductive health conditions in CF are not clearly understood, but are thought to include cystic fibrosis transmembrane regulator (CFTR)-mediated abnormalities, changes in female sex hormones, and other CF health-related factors. In the era of CFTR modulator therapy, new data are necessary to understand the impact of CFTR modulation on contraceptive effectiveness, fertility, and pregnancy outcomes to help guide future clinical care. This article reviews the current scientific knowledge of major reproductive health issues for women with CF.

show abstract

Contraceptive safety among women with cystic fibrosis: a systematic review

Cited by 22 publications

References 22 publications

Practice Guideline: Contraception for Adolescents with Chronic Illness

Practice Guideline: Contraception for Adolescents with Chronic Illness

CE: An Evidence-Based Update on Contraception

Female reproductive health in cystic fibrosis

Contact Info

Product

Resources

About